Clinical Trial Update: Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating a CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, with stated gastric, colon, rectal, esophageal, pancreatic can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Esophageal Cancer
• Gastric Cancer
• Pancreatic Cancer
• Rectal Cancer

Drugs mentioned

• CEA-targeted CAR-T therapy (CAR-T cell therapy targeting carcinoembryonic antigen (CEA))

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Gastric Cancer, Colon Cancer | Phase 1, Phase 2 | Status: UNKNOWN